论文部分内容阅读
目的:探讨米索前列醇预防剖宫产术后出血的临床疗效。方法:2012年6月-2013年6月收治剖宫产术后出血产妇82例,作为研究的对象。随机将其分为对照组和观察组,每组41例。其中对照组采取一般术后的常规护理保守性治疗;而观察组在术后采用米索前列醇通过肛塞的形式给药治疗。比较两组在治疗前后的血压、出血发生率以及术后出血量的情况,并采取统计学方法分析数据。结果:治疗后,在出血量和出血发生率上,观察组均优于对照组,差异具有统计学意义(P<0.05)。结论:米索前列醇预防剖宫产术后出血疗效较好,值得临床大力推广。
Objective: To investigate the clinical efficacy of misoprostol in preventing bleeding after cesarean section. Methods: From June 2012 to June 2013, 82 cases of bleeding maternal after cesarean section were treated as the research object. Randomly divided into control group and observation group, 41 cases in each group. Among them, the control group was treated conservatively after conventional nursing; while the observation group was treated with misoprostol through anal plug after operation. The blood pressure, the incidence of bleeding and the amount of postoperative bleeding were compared between the two groups before and after treatment, and the data were analyzed statistically. Results: After treatment, the bleeding volume and the incidence of bleeding in the observation group were better than those in the control group, the difference was statistically significant (P <0.05). Conclusion: Misoprostol is effective in preventing hemorrhage after cesarean section and is worth promoting clinically.